NCT03896347View on ClinicalTrials.gov

A Study Evaluating 3-Level OLIF Spine Fusion

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

July 1, 2019

Primary Completion Date

February 7, 2020

Study Completion Date

February 13, 2020

Conditions
SpondylolisthesisRetrolisthesisDegenerative Disc Disease
Interventions
OTHER

ViBone®

Viable bone allograft

OTHER

Demineralized Bone Matrix

Demineralized Bone Matrix

OTHER

Bone Morphogenetic Protein

Bone Morphogenetic Protein

Sponsors

Lead Sponsor

Elutia Inc.
All Listed Sponsors
lead

Elutia Inc.

INDUSTRY

NCT03896347 - A Study Evaluating 3-Level OLIF Spine Fusion | Biotech Hunter | Biotech Hunter